Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer
Objective: To determine the effect of estrogen receptor (ER) on programmed death-ligand 1 (PD-L1) expression in type I endometrial cancer (EC). Material and Methods: This retrospective study included 85 patients with type I EC who underwent surgery at Dr. Soetomo Hospital between 2018 and 2022. A ra...
Saved in:
Main Authors: | Setyo Teguh Waluyo (Author), Brahmana Askandar Tjokroprawiro (Author), Anny Setijo Rahaju (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrauterine device and cervical cancer
by: Brahmana Askandar Tjokroprawiro
Published: (2020) -
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
by: Whitney K. Petrie, et al.
Published: (2013) -
Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
by: Darius P. Zlotos, et al.
Published: (2022) -
Expression of programmed cell death ligand-1 and mismatch repair status in endometrial carcinomas
by: Madhubala Rajendran, et al.
Published: (2023) -
The correlation of nutritional status with hematology toxicity of adjuvant chemotherapy in ovarian cancer
by: Kadek Dharma Widhiarta, et al.
Published: (2021)